{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:51:11Z","timestamp":1781945471113,"version":"3.54.5"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bbamcr.2026.120118","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:20:27Z","timestamp":1769127627000},"page":"120118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sox9-dependent acquisition of a drug resistant \u201cmemory state\u201d induces reciprocal expression of Sox6 and Sox7 in BRAF melanoma"],"prefix":"10.1016","volume":"1873","author":[{"given":"John","family":"Abou-Hamad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Delisle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brennan","family":"Garland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Hersi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc A.","family":"Sabourin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6892","key":"10.1016\/j.bbamcr.2026.120118_bb0005","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bbamcr.2026.120118_bb0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ccr.2004.09.022","article-title":"Guilty as charged: B-RAF is a human oncogene","volume":"6","author":"Garnett","year":"2004","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bbamcr.2026.120118_bb0015","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","article-title":"Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF","volume":"116","author":"Wan","year":"2004","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bbamcr.2026.120118_bb0020","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1073\/pnas.0711741105","article-title":"Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity","volume":"105","author":"Tsai","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"19","key":"10.1016\/j.bbamcr.2026.120118_bb0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.21037\/atm.2017.06.09","article-title":"Overcoming resistance to BRAF inhibitors","volume":"5","author":"Arozarena","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.bbamcr.2026.120118_bb0030","first-page":"775","article-title":"Vemurafenib: an evidence-based review of its clinical utility in the treatment of metastatic melanoma","volume":"8","author":"Swaika","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120118_bb0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nm.3984","article-title":"Pan-cancer analysis of the extent and consequences of intratumor heterogeneity","volume":"22","author":"Andor","year":"2016","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.bbamcr.2026.120118_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111153","article-title":"Clonal architectures and driver mutations in metastatic melanomas","volume":"9","author":"Ding","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120118_bb0045","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1038\/s41467-017-01573-6","article-title":"Low neurotrophin receptor CD271 regulates phenotype switching in melanoma","volume":"8","author":"Restivo","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bbamcr.2026.120118_bb0050","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","article-title":"In vivo switching of human melanoma cells between proliferative and invasive states","volume":"68","author":"Hoek","year":"2008","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bbamcr.2026.120118_bb0055","first-page":"1493","article-title":"SOX10-MITF pathway activity in melanoma cells","volume":"13","author":"Tudrej","year":"2016","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.bbamcr.2026.120118_bb0060","doi-asserted-by":"crossref","first-page":"6683","DOI":"10.1038\/ncomms7683","article-title":"Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state","volume":"6","author":"Verfaillie","year":"2014","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbamcr.2026.120118_bb0065","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","article-title":"Toward minimal residual disease-directed therapy in melanoma","volume":"174","author":"Rambow","year":"2018","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bbamcr.2026.120118_bb0070","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41556-020-0547-3","article-title":"Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma","volume":"22","author":"Wouters","year":"2021","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.bbamcr.2026.120118_bb0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/jmedgenet-2021-108105","article-title":"SOX10: 20 years of phenotypic plurality and current understanding of its developmental function","volume":"59","author":"Pingault","year":"2022","journal-title":"J. Med. Genet."},{"issue":"12","key":"10.1016\/j.bbamcr.2026.120118_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105524","article-title":"CEACAM1 is a direct SOX10 target and inhibits melanoma immune infiltration and stemness","volume":"25","author":"Abou-Hamad","year":"2022","journal-title":"iScience"},{"issue":"10","key":"10.1016\/j.bbamcr.2026.120118_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110085","article-title":"SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects","volume":"37","author":"Rosenbaum","year":"2021","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120118_bb0090","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41467-022-28801-y","article-title":"Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma","volume":"13","author":"Capparelli","year":"2022","journal-title":"Nat. Commun."},{"issue":"7494","key":"10.1016\/j.bbamcr.2026.120118_bb0095","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature13121","article-title":"Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma","volume":"508","author":"Sun","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120118_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004877","article-title":"Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma","volume":"11","author":"Shakhova","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbamcr.2026.120118_bb0105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13059-015-0594-4","article-title":"Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma","volume":"16","author":"Cheng","year":"2015","journal-title":"Genome Biol."},{"issue":"4","key":"10.1016\/j.bbamcr.2026.120118_bb0110","first-page":"954","article-title":"Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid","volume":"119","author":"Passeron","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120118_bb0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13046-018-0998-6","article-title":"SOX9 is a dose-dependent metastatic fate determinant in melanoma","volume":"38","author":"Yang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7598","key":"10.1016\/j.bbamcr.2026.120118_bb0120","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature17392","article-title":"sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance","volume":"532","author":"Kaur","year":"2016","journal-title":"Nature"},{"issue":"7658","key":"10.1016\/j.bbamcr.2026.120118_bb0125","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature22794","article-title":"Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance","volume":"546","author":"Shaffer","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbamcr.2026.120118_bb0130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2016.02.003","article-title":"Inhibiting drivers of non-mutational drug tolerance is a salvage strategy for targeted melanoma therapy","volume":"29","author":"Smith","year":"2016","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.bbamcr.2026.120118_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115761","article-title":"How neural crest transcription factors contribute to melanoma heterogeneity, cellular plasticity, and treatment resistance","volume":"22","author":"Wessely","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.bbamcr.2026.120118_bb0140","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1093\/hmg\/ddv267","article-title":"Genomic analysis reveals distinct mechanisms and functional classes of SOX10-regulated genes in melanocytes","volume":"24","author":"Fufa","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"18","key":"10.1016\/j.bbamcr.2026.120118_bb0145","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1158\/0008-5472.CAN-12-4620","article-title":"SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis","volume":"73","author":"Cronin","year":"2013","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bbamcr.2026.120118_bb0150","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/ncb2535","article-title":"Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma","volume":"14","author":"Shakhova","year":"2012","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120118_bb0155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/pcmr.12643","article-title":"Rare, yet relevant tumor cells - a new twist to melanoma cell plasticity","volume":"31","author":"Zingg","year":"2018","journal-title":"Pigm. Cell Melanoma Res."},{"issue":"5","key":"10.1016\/j.bbamcr.2026.120118_bb0160","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/febs.16021","article-title":"Epithelial-to-mesenchymal-like transition events in melanoma","volume":"289","author":"Pedri","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.bbamcr.2026.120118_bb0165","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1038\/ncomms6712","article-title":"Low MITF\/AXL ratio predicts early resistance to multiple targeted drugs in melanoma","volume":"5","author":"Muller","year":"2015","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bbamcr.2026.120118_bb0170","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.cell.2015.07.061","article-title":"Non-genomic and immune evolution of melanoma acquiring MAPKi resistance","volume":"162","author":"Hugo","year":"2015","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.bbamcr.2026.120118_bb0175","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202051683","article-title":"CDK7 and MITF repress a transcription program involved in survival and drug tolerance in melanoma","volume":"22","author":"Berico","year":"2021","journal-title":"EMBO Rep."},{"issue":"5","key":"10.1016\/j.bbamcr.2026.120118_bb0180","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/pcmr.12498","article-title":"The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations","volume":"29","author":"Meeth","year":"2016","journal-title":"Pigm. Cell Melanoma Res."},{"issue":"6","key":"10.1016\/j.bbamcr.2026.120118_bb0185","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1158\/1535-7163.MCT-16-0535","article-title":"The slow cycling phenotype: a growing problem for treatment resistance in melanoma","volume":"16","author":"Ahn","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"9","key":"10.1016\/j.bbamcr.2026.120118_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107472","article-title":"Gene signature reveals decreased SOX10-dependent transcripts in malignant cells from immune checkpoint inhibitor-resistant cutaneous melanomas","volume":"26","author":"Purwin","year":"2023","journal-title":"iScience"},{"issue":"5","key":"10.1016\/j.bbamcr.2026.120118_bb0195","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jid.2021.10.007","article-title":"Vemurafenib drives epithelial-to-mesenchymal transition gene expression in BRAF inhibitor-resistant BRAF(V600E)\/NRAS(Q61K) melanoma enhancing tumor growth and metastasis in a bioluminescent murine model","volume":"142","author":"Jandova","year":"2022","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.bbamcr.2026.120118_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031477","article-title":"Sox10 controls migration of B16F10 melanoma cells through multiple regulatory target genes","volume":"7","author":"Seong","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bbamcr.2026.120118_bb0205","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/jid.2014.128","article-title":"SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity","volume":"134","author":"Graf","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"34","key":"10.1016\/j.bbamcr.2026.120118_bb0210","doi-asserted-by":"crossref","first-page":"36370","DOI":"10.18632\/oncotarget.5639","article-title":"Regulation of SOX10 stability via ubiquitination-mediated degradation by Fbxw7alpha modulates melanoma cell migration","volume":"6","author":"Lv","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120118_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/cells13010073","article-title":"Sox10-deficient drug-resistant melanoma cells are refractory to oncolytic RNA viruses","volume":"13","author":"Abou-Hamad","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120118_bb0220","doi-asserted-by":"crossref","first-page":"574","DOI":"10.18632\/oncotarget.13479","article-title":"Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bbamcr.2026.120118_bb0225","first-page":"885","article-title":"MicroRNA-613 induces the sensitivity of gastric cancer cells to cisplatin through targeting SOX9 expression","volume":"11","author":"Xue","year":"2019","journal-title":"Am. J. Transl. Res."},{"issue":"4","key":"10.1016\/j.bbamcr.2026.120118_bb0230","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/15384101.2017.1395533","article-title":"SOX9\/miR-130a\/CTR1 axis modulates DDP-resistance of cervical cancer cell","volume":"17","author":"Feng","year":"2018","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.bbamcr.2026.120118_bb0235","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1002\/jcb.26865","article-title":"MiR-34c\/SOX9 axis regulates the chemoresistance of ovarian cancer cell to cisplatin-based chemotherapy","volume":"120","author":"Xiao","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"10","key":"10.1016\/j.bbamcr.2026.120118_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107742","article-title":"Stem cell determinant SOX9 promotes lineage plasticity and progression in basal-like breast cancer","volume":"31","author":"Christin","year":"2020","journal-title":"Cell Rep."},{"issue":"15","key":"10.1016\/j.bbamcr.2026.120118_bb0245","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1093\/nar\/gkac652","article-title":"SOX9 reprograms endothelial cells by altering the chromatin landscape","volume":"50","author":"Fuglerud","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.bbamcr.2026.120118_bb0250","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s41556-023-01184-y","article-title":"The pioneer factor SOX9 competes for epigenetic factors to switch stem cell fates","volume":"25","author":"Yang","year":"2023","journal-title":"Nat. Cell Biol."},{"issue":"29","key":"10.1016\/j.bbamcr.2026.120118_bb0255","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2202015119","article-title":"Sox9 directs divergent epigenomic states in brain tumor subtypes","volume":"119","author":"Sardar","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.bbamcr.2026.120118_bb0260","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120118_bb0265","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41467-017-02391-6","article-title":"Perturbation-response genes reveal signaling footprints in cancer gene expression","volume":"9","author":"Schubert","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bbamcr.2026.120118_bb0270","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2015","journal-title":"OMICS: J. Integr. Biol."},{"issue":"2","key":"10.1016\/j.bbamcr.2026.120118_bb0275","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1039\/C5MB00663E","article-title":"ReactomePA: an R\/Bioconductor package for reactome pathway analysis and visualization","volume":"12","author":"Yu","year":"2016","journal-title":"Mol. BioSyst."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488926000145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488926000145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:20:52Z","timestamp":1781943652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488926000145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0167488926000145"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2026.120118","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sox9-dependent acquisition of a drug resistant \u201cmemory state\u201d induces reciprocal expression of Sox6 and Sox7 in BRAF melanoma","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2026.120118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120118"}}